Today, the House of Representatives passed S. 3187, the Food and Drug Administration Safety and Innovation Act, the compromise bill to reform user fee programs for drugs and medical devices. The bipartisan legislation passed the House by a voice vote.
Rep. Pitts' statement follows:
"After weeks of negotiation with the Senate, came to an agreement on legislation to reform Food and Drug Administration user fee programs. Just as we worked together with Democrats here in the House, we met with our Senate counterparts and created a bill that we can all agree on. We fully expect it to move through the other chamber and on to the President in the next few days.
"This is critical legislation both to patients eagerly awaiting new cures and to companies working on the cutting edge of medical technology. We need transparent and predictable reviews that ensure devices are safe. Continued growth and innovation in this industry is dependent on good regulation.
"Our work doesn't end with the President's signature. As Chairman of the Energy and Commerce Health Subcommittee, I'm going to closely monitor the implementation of this bill to make sure that FDA stays on track. Consistent oversight is necessary to make sure that the agreements in the legislation are upheld by government regulators."